790208 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Inosine mitigated diabetic peripheral neuropathy via modulating GLO1/AGEs/RAGE/NF-κB/Nrf2 and TGF-β/PKC/TRPV1 signaling pathways |
2022-01-01 |
10.1016/j.biopha.2021.112395 |
Abdelkader Noha F., Ibrahim Sherehan M., Moustafa Passant E., Elbaset Marawan A. |
790207 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Transitioning pre-clinical glioblastoma models to clinical settings with biomarkers identified in 3D cell-based models: A systematic scoping review |
2022-01-01 |
10.1016/j.biopha.2021.112396 |
Phon Brandon Wee Siang, Kamarudin Muhamad N.A., Bhuvanendran Saatheeyavaane, Radhakrishnan Ammu K. |
790206 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
DA-9805 protects dopaminergic neurons from endoplasmic reticulum stress and inflammation |
2022-01-01 |
10.1016/j.biopha.2021.112389 |
Kang Sora, Piao Ying, Kang Young Cheol, Lim Suyeol, Pak Youngmi Kim |
790205 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Natural and chemical compounds as protective agents against cardiac lipotoxicity |
2022-01-01 |
10.1016/j.biopha.2021.112413 |
Yarmohammadi Fatemeh, Hayes A. Wallace, Karimi Gholamreza |
790204 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Ursolic acid does not change the cytokine levels following resistance training in healthy men: A pilot balanced, double-blind and placebo-controlled clinical trial |
2022-01-01 |
10.1016/j.biopha.2021.112289 |
Lobo Patrícia Cristina Barreto, Pimentel Gustavo Duarte |
790203 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Ginsenoside Rg3 inhibits angiogenesis in gastric precancerous lesions through downregulation of Glut1 and Glut4 |
2022-01-01 |
10.1016/j.biopha.2021.112086 |
Zeng Zhongzhen, Nian Qing, Chen Nianzhi, Zhao Maoyuan, Zheng Qiao, Zhang Gang, Zhao Ziyi, Chen Yu, Wang Jundong, Zeng Jinhao, Gong Daoyin, Tang Jianyuan |
790202 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Exploring the antiplatelet activity of serotonin 5-HT2A receptor antagonists bearing 6-fluorobenzo[d]isoxazol-3-yl)propyl) motif– as potential therapeutic agents in the prevention of cardiovascular diseases |
2022-01-01 |
10.1016/j.biopha.2021.112424 |
Marcinkowska Monika, Kubacka Monika, Zagorska Agnieszka, Jaromin Anna, Fajkis-Zajaczkowska Nikola, Kolaczkowski Marcin |
790201 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Emerging role of long non-coding RNAs in endothelial dysfunction and their molecular mechanisms |
2022-01-01 |
10.1016/j.biopha.2021.112421 |
Jayasuriya Ravichandran, Ganesan Kumar, Xu Baojun, Ramkumar Kunka Mohanram |
790200 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Review of anticancer potentials and structure-activity relationships (SAR) of rhodanine derivatives |
2022-01-01 |
10.1016/j.biopha.2021.112406 |
Yin Lim Ju, bin Ahmad Kamar Ahmad Khairul Daniel, Fung Gan Tjin, Liang Chin Tze, Avupati Vasudeva Rao |
790199 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Anticancer activity of oleanolic acid and its derivatives: Recent advances in evidence, target profiling and mechanisms of action |
2022-01-01 |
10.1016/j.biopha.2021.112397 |
Tang Zhong-Yuan, Li Yang, Tang Yu-Ting, Ma Xiao-Dong, Tang Ze-Yao |